In adults with undiagnosed respiratory symptoms, dyspnea impact was worse in those with PRISm vs undiagnosed asthma or COPD.

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

Baxter International, Inc. BAX announced the launch of its next-generation airway clearance system, The Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis ...

Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...

The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...

The following is a summary of “Comparative Effectiveness of qSOFA, CURB-65, and PSI in Predicting Pneumonia Hospitalization ...

NEW YORK, May 19 (UPI) --Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for respiratory symptoms in ...

One of the most deprived places in the country hopes to be "smoke free" by 2030 as Knowsley Council aims to reduce smoking ...

Researchers mapped the biological influences on 4,775 plasma proteins, revealing the interplay of modifiable and ...

The mission of Blessed Home Health Care in Oregon is to provide health services to patients in the comfort and dignity of their own home.

Which habit is common to some men, women and sadly, minors, but damages the heart and lungs, among other organs of the body?